Here are Thursday’s biggest calls on Wall Street:
Citi initiates Gilead Sciences as buy. The firm said it’s bullish on the biotech company’s HIV franchise.
“We are initiating coverage of Gilead with a Buy rating and a $125 TP.” Piper Sandler upgrades Campbell Soup to overweight from neutral Piper said it sees an attractive entry point for the stock. “We upgrade CPB from Neutral to Overweight on better long-term growth expectations with its Rao’s brand. It has improving US measured retail sales and volume trends (ex- SOVO acquired brands). Despite better trends, the stock has pulled back ~15% since mid- September, which we believe presents a good buying opportunity.”
UBS initiates Cogent as buy. The firm said it sees meaningful revenue acceleration for the internet services company.
“We are initiating CCOI with a Buy rating and $102 PT. Oppenheimer reiterates Nvidia as buy The firm said it’s bullish heading into earnings next week. “We see NVDA best positioned in AI, benefiting from full-stack AI hardware/software. Reiterate Outperform and raise price target to $175 from $150.”
Oppenheimer reiterates NVIDIA Corp as buy. The firm said it’s bullish heading into earnings next week.
“We see NVDA best positioned in AI, benefiting from full-stack AI hardware/software. Reiterate Outperform and raise price target to $175 from $150.”
Jefferies reiterates Tesla Motors as hold. The firm raised its price target on the stock to $300 per share from $195.
“Tesla should take advantage of shares re-rating 30% back > $1trn since Trump’s election to raise equity. Assuming markets remain competitive, de-regulation raises the growth path but also the investment requirements for Tesla and competitors (AV, Robots) in ventures where returns remain unclear.”
Morgan Stanley upgrades Doximity, Inc. to equal weight from underweight. Morgan Stanley said consensus estimates are too low for the online networking services for medical professionals.
“Doximity is seeing renewed momentum in its business and conservative Q4 guidance suggests room for upward revisions to estimates.”
Evercore ISI opens a negative tactical call on Target. The firm said it sees sales trend deceleration heading into earnings next week.
“We are initiating a negative TAP call on TGT ahead of its earnings on 11/20, with potential downside to $140.”
JPMorgan reiterates Netflix as overweight. The firm said investor sentiment remains robust on the streaming giant.
“We believe investor sentiment remains strong into year-end on the 4Q content slate, along with confidence in NFLX meeting & beating its +11%-13% 2025 revenue outlook & 28% 2025 operating margin guide, while delivering meaningful FCF growth.”
Barclays upgrades American Airlines to equal weight from underweight. Barclays said it sees business travel improving and renegotiated card agreements for the airline.
“We upgrade American to Equal Weight as balance sheet leverage fades, business travel share has room to improve and the carrier renegotiates co-brand card agreements in 2025.”
Morgan Stanley reiterates Meta Platforms, Inc. as overweight. The firm said Meta is a major AI beneficiary.
” META’s scale and distribution have accelerated Meta AI adoption to levels comparable with ChatGPT and Gemini, despite only being released in April 2024.”
Needham reiterates Amazon.com as buy. Needham raised its price target on the stock to $250 per share from $210 after a series of channel checks.
” AMZN’s focus is on customer-centric innovation, and most of its product development comes directly from customer feedback. AMZN’s culture allows every FTE (full time equivalent) to pitch ideas and see them work-shopped, implemented and scaled quickly.”
Jefferies reiterates Microsoft as buy. Jefferies said it’s getting even more bullish on the stock following a visit to company headquarters. “We believe MSFT can rerate as it continues to execute.”
Comments